Permira Advisers LLP, Europe’s biggest buyout firm, will purchase Arysta LifeScience Corp. for about 250 billion yen ($2.2 billion) in its first acquisition in Japan.
Permira will spend 100 billion yen in cash and borrow the rest, said
spokeswoman Minako Hattori, declining to name the banks involved. Tokyo-based
Arysta, a closely held maker of farm chemicals such as insecticides, provides
crop protection and develops pharmaceutical additives, and veterinary medicines.
The purchase, Japan’s biggest buyout this year, marks Permira’s entrance
into the world’s second-largest economy, where buyouts are expected to grow.
Private equity and management buyouts targeted at Japanese companies have grown
7.5% to $6.7 billion so far this year. That represents only 1.5% of similar
transactions in the U.S.
2/3 articles remaining | Register to continue reading.